Allergan reports 5% increase in Q1 net revenues

25 May 2017

Allergan has reported a total net revenue of $3.6 billion in its continuing operations performance for the first quarter of 2017.

According to a news release from Allergan, the increase of 5%, with the prior year quarter, was driven by higher revenues in sectors including facial aesthetics, Botox Therapeutic, eye-care and regenerative medicine products.  

Brent Saunders, Allergan chairman and CEO said, “Many of our key brands continued to deliver significant year-over-year growth, led by Botox, our Juv.derm collection of fillers, and our regenerative medicine business, Linzess and Lo Loestrin.”


Log-in to post a comment